Drug
Jtz 951
Jtz 951: highest development phase Phase 1, developed by Shionogi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| JTZ-951, 14C-JTZ-951 NCT02805244 | Phase 1 | Anemia of Chronic Kidney Disease |
Latest
No recent events.
Follow Jtz 951 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.